Introduction, Results, and Discussion
Among the many significant questions that have arisen regarding the susceptibility of oral mucosa to HIV-1 infection are the following: (1) Is the oral mucosa a significant route of infection of HIV-1? (2) If so, how does the HIV-1 virus evade the innate defense mechanisms (i.e., saliva) and penetrate the mucosa? (3) Which cells are primarily infected by HIV-1 in the oral mucosa? (4) If the oral cavity is not a significant route of infection, can it serve as a reservoir of HIV-1 infection, i.e., inside-out infection from the blood? The literature and data presented in the recent HIV workshop on innate/specific mucosal immunity (see Workshop Reports, this issue), it is clear that answers to the above questions are wanting.
Is the oral mucosa a significant route of infection?
The conventional wisdom is that HIV-1 transmission through oral mucosa and its secretions is uncommon (Rothenberg et al., 1998; Cohen et al., 2000) , due to a combination of anatomical and biochemical factors (Baron et al., 1999; Shugars et al., 2002) . However, there is evidence that blood and seminal proteins in saliva can protect HIV-1 from the killing effects of saliva (Baron et al., 1999 (Baron et al., , 2000 . Moreover, two-week-old CXCR4-positive keratinocytes are susceptible to low-grade infection by HIV-1 under specific conditions in vitro; furthermore, the HIV-1 is able to infect adjacent leukocytes (Liu et al., 2003) . Analysis of our data suggests that CXCR4 expression in oral mucosa is very limited (Jotwani et al., 2004) ; moreover, other groups (Quiñones-Mateu et al., 2003) have questioned the in vitro methods previously used (Liu et al., 2003) to promote HIV-1 infection, and have not independently been able to demonstrate HIV-1 infection of keratinocytes. The main cell types in gingiva which can express HIV-1 receptors/co-receptors are dendritic cells (DCs), CD4+ Tlymphocytes, and macrophages. Studies performed in our laboratory have demonstrated that oral mucosa, like other mucosal surfaces, contains at least two subsets of DCs: Langerhans cells (LCs) and dermal DCs (DDCs) (Jotwani and Cutler, 2003) . It is generally agreed that DCs capture HIV-1 at entry sites, migrate to lymph nodes, and transmit HIV-1 to CD4+ T-cells. Recent evidence suggests that HIV-1 uses a spectrum of receptors belonging to the mannose C-type lectin receptor (MCLR) family to attach to different DC subsets (Turville et al., 2002) . These include DC-specific ICAM-3 grabbing non-integrin (DC-SIGN) expressed by DDCs, macrophage mannose receptors (MR) expressed by DDCs, and macrophages and Langerin expressed by LCs. However, though these receptors can mediate virus attachment and transmission in vitro, their in vivo relevance in HIV-1 pathogenesis is uncertain.
In previously published studies, we used immunohistochemistry to analyze gingival samples from a population of chronic periodontitis (CP) subjects and healthy adult controls (Jotwani et al., 2004) . Our results established that CP is accompanied by a significant increase in the numbers of DC-SIGN+ DDCs and a trend for increased MR in the lamina propria. Both DC-SIGN and MR are significantly associated in a linear fashion with gingival inflammation. The expression of Langerin in inflammation appears to decrease. This is consistent with the efflux of LCs out of the epithelium to the underlying lamina propria, in response to inflammatory signals. This is particularly noteworthy in view of evidence, via double-immunofluorescence analysis, that DDCs and LCs contribute to the CD83+ mature DCs pool (Jotwani and Cutler, 2003) , present in the T-cell-rich lamina propria (Jotwani et al., 2001) ; moreover, CD83+ DCs form immune conjugates with CD4+ T-cells in situ (Jotwani and Cutler, 2003) . Thus, the 'stage is set' for a productive HIV-1 infection of T-cells in the oral disease CP. Changes in expression of factors relevant to HIV-1 infection are outlined in the Table. O Or ra al l M Mu uc co os sa al l E Ex xp pr re es ss si io on n o of f H HI IV V--1 1 R Re ec ce ep pt to or rs s, , C Co o--r re ec ce ep pt to or rs s, , a an nd d ␣ ␣--d de ef fe en ns si in ns s: : T Ta ab bl le ea au u o of f R Re es si is st ta an nc ce e o or r S Su us sc ce ep pt ti ib bi il li it ty y t to o H HI IV V I In nf fe ec ct ti io on n? ?
Are all the players present?
Co-receptor expression is critical to HIV-1 infection. HIV-1 enters CD4+ T-lymphocytes and macrophages via CD4, in conjunction with chemokine receptors CCR5 and or CXCR4. Infection is mediated by binding of the surface subunit of HIV-1 envelope glycoprotein (Env), gp120, to CD4 on the target cell (Simmons et al., 2000) . This interaction results in a conformational change in gp120 that allows it to bind to the chemokine receptor (e.g., CCR5). It has been observed that, during initial stages of HIV-1 transmission through sexual contact, non-syncytium-inducing (NSI) or macrophage (M)tropic primary viruses predominate and use CCR5 (Connor et al., 1997) . In contrast, in the late stages of infection, syncytiuminducing (SI) T-cell line (T)-tropic viruses emerge which preferentially use CXCR4. SI viruses are more virulent and are associated with higher rates of CD4 + -T-cell decline. It is generally believed that expression and regulation of HIV-1 receptors/co-receptors at different anatomic sites (Zhang et al., 1998; Jameson et al., 2002) govern their susceptibility or resistance to infection with HIV-1. Vaginal mucosa is thought to be more resistant than rectal mucosa to HIV-1 infection, due in part to low expression of CCR5. In the rectum, numerous DC-SIGN + CCR5+ CD4+ DCs and CD4+ CCR5+ cells are expressed throughout the lamina propria, beneath the luminal epithelium, whereas in the vagina, subepithelial DCs in the lamina propria express moderate levels of DC-SIGN, and a small number of these cells co-express CCR5 (Jameson et al., 2002) . In the colonic epithelium, there is a predominant apical expression of CXCR4 and CCR5, suggesting that intestinal epithelial cells can serve as a target for entry of HIV-1 across the colonic mucosa (Dwinell et al., 1999) .
The importance of co-receptor CCR5 in HIV-1 pathogenesis is also supported by the finding that a genetic mutation in CCR5 delta 32 (which occurs naturally in a small percentage of individuals) makes them highly resistant to HIV-1 infection (Huang et al., 1996) . In view of these observations and the results of our published study documenting low expression of CCR5, and restricted expression of CXCR4 in oral mucosa (Jotwani et al., 2004) , it is reasonable to assume that these factors may play a distinct role in the resistance of gingiva to infection with HIV-1.
Resistance to HIV-1 infection in human gingiva can also be mediated by antimicrobial proteins, the defensins. Analysis of ␣-defensin-1 expression in human gingiva by conventional RT-PCR and quantitative real-time PCR demonstrates their expression during health (Jotwani et al., 2004) . Several studies have independently confirmed the anti-HIV potential of ␣defensins-1-3 (Zhang et al., 2002; Mackewicz et al., 2003) . Anti-HIV-1 activity of ␣-defensins has been shown to operate at least at two levels, including direct inactivation of virus particles and affecting the ability of target CD4+ T-cells to replicate the virus (Mackewicz et al., 2003) . Regarding the cells which produce ␣-defensin-1, -2, and -3, neutrophils are recognized as a principal source (Lehrer and Ganz, 2002) . However additional sources have been described, including NK cells, ␥␦ T-cells, B-cells, and monocytes/macrophages (Agerberth et al., 2000) . Recent evidence suggests that monocytes may be principal sources of ␣-defensins (Mackewicz et al., 2003) . Neutrophils increasingly infiltrate the gingival mucosa during CP and are likely to be the major sources of ␣-defensins (Dale, 2002) , consistent with our evidence of significantly increased expression of ␣-defensin-1 during CP (Jotwani et al., 2004) . Analysis of these data underscores the need for the identification of the oral mucosal cells expressing ␣-defensins. The inflammatory infiltrate in CP contains many immune cell types (Jotwani et al., 2001) , which, in other studies, have been shown to contain ␣-defensin activity (Agerberth et al., 2000; Lehrer and Ganz, 2002) . Recently, it has been shown that human ␤-defensin (hBD)-2 and -3, produced by human oral epithelial cells, can also block HIV-1 replication via a direct interaction with virions and through modulation of the CXCR4 co-receptor in vitro (Quiñones-Mateu et al., 2003) . hBD-1 and hBD-2 are constitutively expressed on healthy gingiva. Constitutive expression of hBD-2 (10 M per gram of tissue) is sufficient to inhibit replication of the HIV-1 X4 isolate (Sawaki et al., 2002; Quiñones-Mateu et al., 2003) .
In conclusion, we have observed that, in gingival health, the low expression patterns of HIV-1 receptors/co-receptors by gingival cells suggest an unfavorable environment for infection with HIV-1. During CP, there is an increase in the number of cells co-expressing HIV-1 receptors/co-receptors; however, this is accompanied with ten-fold increases in ␣-defensin-1, known to have potent anti-HIV-1 activity. Further studies are required to determine whether oral mucosal DCs and T-cells are infected in HIV-1 + subjects, and to clarify the role of defensins (both ␣ and ␤) in oral mucosa, so that protective strategies for other mucosal surfaces can be developed. ␣-defensins markedly increased
